ストックスクリーナーアプリを入手
20.51
7.49%
1.43
アフターアワーズ：
20.51
前日終値:
$19.08
開ける：
$19.91
24時間の取引高:
1.31M
Relative Volume:
1.33
時価総額：
$1.03B
収益：
$290.38M
当期純損益:
$-21.03M
株価収益率:
-47.76
EPS:
-0.4294
ネットキャッシュフロー:
$-54.99M
1週間 パフォーマンス:
-1.49%
1か月 パフォーマンス:
-11.52%
6か月 パフォーマンス:
+6.88%
1年 パフォーマンス:
-23.33%
1日の値動き範囲:
$19.70
$20.80
1週間の範囲:
$19.05
$21.03
52週間の値動き範囲:
$15.59
$35.87
Staar Surgical Co Stock (STAA) Company Profile
Compare STAA vs ISRG, BDX, RMD, ALC, MDLN
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STAA
Staar Surgical Co
|
20.51 | 1.03B | 290.38M | -21.03M | -54.99M | -0.4294 |
ISRG
Intuitive Surgical Inc
|
405.18 | 143.14B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.82 | 50.07B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
222.00 | 32.02B | 5.54B | 1.52B | 1.74B | 10.37 |
ALC
Alcon Inc
|
64.47 | 31.16B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
34.70 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Staar Surgical Co Stock (STAA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-09 | アップグレード | Canaccord Genuity | Hold → Buy |
| 2026-02-03 | 開始されました | Wedbush | Neutral |
| 2026-01-16 | 再開されました | Morgan Stanley | Underweight |
| 2025-04-21 | 開始されました | Wells Fargo | Equal Weight |
| 2025-02-12 | ダウングレード | BTIG Research | Buy → Neutral |
| 2025-02-12 | ダウングレード | Jefferies | Buy → Hold |
| 2025-02-12 | ダウングレード | Mizuho | Outperform → Neutral |
| 2025-02-12 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-06-11 | アップグレード | BTIG Research | Neutral → Buy |
| 2024-03-11 | アップグレード | Stifel | Hold → Buy |
| 2023-12-05 | ダウングレード | Needham | Buy → Hold |
| 2023-12-04 | 開始されました | Morgan Stanley | Equal-Weight |
| 2023-09-15 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2023-08-03 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2023-06-07 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-04-17 | 開始されました | Piper Sandler | Neutral |
| 2023-02-06 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-12-28 | 繰り返されました | BTIG Research | Buy |
| 2022-12-08 | 開始されました | Stifel | Hold |
| 2022-11-07 | アップグレード | Sidoti | Neutral → Buy |
| 2022-10-14 | 再開されました | Stephens | Overweight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-04-08 | 開始されました | Needham | Buy |
| 2022-03-28 | アップグレード | The Benchmark Company | Hold → Buy |
| 2022-03-18 | アップグレード | BTIG Research | Neutral → Buy |
| 2021-07-09 | 開始されました | Oppenheimer | Perform |
| 2021-01-19 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2020-10-26 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-08-31 | アップグレード | Sidoti | Neutral → Buy |
| 2020-08-06 | 繰り返されました | The Benchmark Company | Buy |
| 2020-07-06 | ダウングレード | Sidoti | Buy → Neutral |
| 2020-06-24 | ダウングレード | BTIG Research | Buy → Neutral |
| 2020-06-15 | 開始されました | Jefferies | Buy |
| 2019-12-04 | 開始されました | BTIG Research | Buy |
| 2018-09-24 | 繰り返されました | The Benchmark Company | Buy |
| 2018-08-06 | 再開されました | The Benchmark Company | Buy |
| 2017-11-20 | 繰り返されました | The Benchmark Company | Buy |
| 2017-08-14 | 繰り返されました | The Benchmark Company | Buy |
| 2017-03-03 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-18 | アップグレード | The Benchmark Company | Hold → Buy |
| 2013-09-10 | 再開されました | The Benchmark Company | Buy |
| 2013-02-28 | 繰り返されました | The Benchmark Company | Buy |
| 2012-11-01 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2012-03-02 | 開始されました | Northland Securities | Outperform |
| 2011-10-25 | 繰り返されました | The Benchmark Company | Buy |
| 2010-10-12 | 開始されました | Morgan Joseph | Buy |
| 2010-05-11 | 開始されました | Benchmark | Buy |
すべてを表示
Staar Surgical Co (STAA) 最新ニュース
Glucotrack announces pricing of public offering - Medical Buyer
STAAR Surgical approves USD 50M share repurchase - Medical Buyer
STAAR Surgical Company (STAA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Why Staar Surgical Stock Soared Today - The Motley Fool
A Look at Staar Surgical Co (STAA) After 7.5% Gain -- GF Value $33.27 vs Price $20.51 - GuruFocus
Why Staar Surgical Stock Soared Today - The Motley Fool
STAA Looks 38.4% Undervalued on GF Value™ Despite Profit Challen - GuruFocus
STAAR Surgical stock ticks higher on $50M buyback authorization - Investing.com
Why is STAAR Surgical stock climbing today? By Investing.com - Investing.com Canada
Why is STAAR Surgical stock climbing today? - Investing.com
STAAR Surgical authorizes $50 million share buyback program - Investing.com
STAAR Surgical Company (STAA) Stock forecasts - Yahoo Finance Singapore
Is Staar Surgical Co (STAA) a Bargain After 4.1% Drop? GF Value Says Undervalued - GuruFocus
STAAR Surgical Company (STAA) Stock Forecasts - Yahoo Finance
STAA Rated Buy by Jefferies -- Price Target Lowered to $23 - GuruFocus
STAAR Surgical Q2 EPS $0.16 beats $0.15 estimate; sales up 111% - scanx.trade
Cataract Surgery Devices Market Size, Share & Growth Report, 2035 - snsinsider.com
STAAR Surgical Company (STAA) Stock Analysis: Exploring a 31% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
A Look at Staar Surgical Co (STAA) After 5.2% Decline -- GF Value $33.38 vs Price $21.24 - GuruFocus
Learn Why The Bull Case For STAAR Surgical Stock Could Change Following Earnings Rebound - simplywall.st
Is STAAR Surgical (STAA) A Bargain Following Its Profit Turnaround And China Led Sales Rebound? - simplywall.st
STAAR Surgical (STAA) Swings To Profit On China Rebound - Yahoo Finance
STAAR Surgical (STAA) Says Implantable Lenses Are Taking Share From Laser Surgery - simplywall.st
Staar Surgical Co (STAA) Shares Fall 3.4% -- What GF Score of 81 Tells Investors - GuruFocus
STAAR Surgical hires former CEO to lead commercial team - MedTech Dive
STAAR Surgical Names David Bailey as Chief Commercial Officer with Detailed Compensation Package - Kalkine Media
STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer - Minichart
STAAR Surgical Releases Landmark Global Report Showing Structural Multi-Market Shift Toward Lens-Based Vision Correction - Finviz
U.S. laser procedures fell 52% as use of implantable lenses rose 76% - Stock Titan
STAA Looks 29.6% Undervalued on GF Value™ - GuruFocus
Ex-STAAR Surgical CEO David Bailey Rejoins as Chief Commercial Officer - Medical Product Outsourcing
Former CEO returns as STAAR's vision-lens revenue grows more than tenfold - Stock Titan
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more - glance.eyesoneyecare.com
3 Stocks Riding The Smart Glasses And Eye Care Shift Investors Should Watch - simplywall.st
Why Did STAA Stock Surge More Than 19% After-Hours Today? - Stocktwits
STAAR Surgical names Ben Park as CTO - medicalbuyer.co.in
STAAR Surgical Company (STAA) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
STAAR Surgical Appoints Ben Park as Chief Technology Officer - VisionMonday.com
STAAR Surgical Hires Align Exec Dr. Ben Park as CTO - Medical Product Outsourcing
STAAR Surgical Names Medtech Innovator and Platform Builder Ben Park as Chief Technology Officer - Business Wire
STAAR Surgical hires a CTO as it prepares new eye products - Stock Titan
Is STAAR Surgical (STAA) Cheap Following Its Recent Share Price Slide? - simplywall.st
STAAR Surgical Names Warren Foust President and Chief Executive Officer - thekeyexecutives.com
Madison Avenue Partners, LP Buys Staar Surgical Co (STAA) -- Sha - GuruFocus
STAAR (STAA) Q2 2026 Earnings Call Transcript - The Globe and Mail
5 Insightful Analyst Questions From STAAR Surgical’s Q2 Earnings Call - Yahoo Finance
STAAR Surgical CEO Warren Foust Reports PSU Vesting and New Equity Grants on August 14, 2026 - Kalkine Media
STAAR Surgical CFO Deborah Andrews Reports August 2026 Stock Vesting and New Equity Grants - Kalkine Media
STAAR Surgical (STAA) awards CFO RSUs, options and PSUs - Stock Titan
Staar Surgical Co (STAA) 財務データ
収益
当期純利益
現金流量
EPS
0.00%
0.51%
大文字化:
|
ボリューム (24 時間):